PCM
ROIV icon

Penserra Capital Management’s Roivant Sciences ROIV Stock Holding History

Penserra Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,771
Closed -$72K – 1175
2022
Q2 		$72K Buy
17,771
+210
+1% +$834 ﹤0.01% 825
2022
Q1 		$86K Sell
17,561
-30,489
-63% -$201K ﹤0.01% 883
2021
Q4 		$484K Buy
+48,050
New +$400K 0.01% 537

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Penserra Capital Management's ROIV Position: Q3 2022 in Review

Penserra Capital Management sold out of Roivant Sciences (ROIV) in Q3 2022, closing a stake of 17,771 shares — an estimated $72K sold.

Penserra Capital Management first reported a position in ROIV in Q4 2021 and held it in 3 quarters. The position peaked at $484K in Q4 2021. 78 funds tracked by Wall St. Rank hold ROIV as of Q3 2022.

  • Penserra Capital Management reported no remaining Roivant Sciences position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 17,771 Roivant Sciences shares in Q3 2022, an estimated $72K.
  • Penserra Capital Management first reported a position in Roivant Sciences in Q4 2021 and held it in 3 quarters.
  • Penserra Capital Management's Roivant Sciences position peaked at $484K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.